New leadership at Celularity (NASDAQ: CELU) as Gordon joins board
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Celularity Inc. named two long-time senior executives to new top roles. Effective June 19, 2026, the Board appointed Steven N. Gordon, Esq. as Chief Operating and Administrative Officer and also elected him to the Board of Directors. He has been EVP, Business Affairs since January 2026 and has worked on the company’s financing, restructuring and strategic initiatives.
The Board also appointed K. Harold Fletcher, Esq. as Chief Legal and Strategy Officer and Corporate Secretary, after serving as EVP, Legal and Strategy and previously as General Counsel and Chief Compliance Officer. The company states there are no family relationships or special arrangements related to these appointments, and that any detailed compensation terms or related-party transactions will be described in later filings if required.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Par value: $0.0001 per share
Warrant exercise price: $11.50 per share
Commission File Number: 001-38914
+2 more
5 metrics
Par value
$0.0001 per share
Class A Common Stock par value
Warrant exercise price
$11.50 per share
Warrants exercisable for one-tenth of one share
Commission File Number
001-38914
Exchange Act registration reference
IRS Employer Identification Number
83-1702591
Celularity federal tax ID
Effective appointment date
June 19, 2026
Date officers and director appointments became effective
Key Terms
Emerging growth company, Chief Operating and Administrative Officer, Chief Legal and Strategy Officer, corporate governance, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Chief Operating and Administrative Officer financial
"appointed Steven N. Gordon, Esq. as the Company’s Chief Operating and Administrative Officer"
Chief Legal and Strategy Officer financial
"appointed K. Harold Fletcher, Esq. as the Company’s Chief Legal and Strategy Officer and Corporate Secretary"
corporate governance financial
"Mr. Fletcher has substantial experience in corporate governance, securities law, strategic transactions"
Corporate governance is the system of rules, roles and oversight that determines how a company is directed and controlled, including the responsibilities of its board, executives and shareholders. Like the steering wheel and map for a car trip, it shapes decisions, sets checks on power and defines who can hold leaders accountable; strong governance reduces risk, builds trust and helps investors judge whether a company is likely to protect capital and deliver reliable returns.
securities law regulatory
"Mr. Fletcher has substantial experience in corporate governance, securities law, strategic transactions"
Securities law is the set of rules that govern the creation, sale and trading of financial instruments such as stocks and bonds, designed to ensure accurate disclosure and fair behavior in markets. Like traffic laws that keep drivers honest and prevent accidents, these rules require truthful information, forbid fraud and provide enforcement tools so investors can make informed choices and rely on a basic level of market integrity.
FAQ
What executive leadership changes did Celularity (CELU) announce?
Celularity appointed Steven N. Gordon as Chief Operating and Administrative Officer and K. Harold Fletcher as Chief Legal and Strategy Officer and Corporate Secretary, both effective June 19, 2026, formalizing roles they had already been performing as executive vice presidents.
Did Celularity (CELU) add a new member to its Board of Directors?
Yes. Celularity’s Board appointed Steven N. Gordon as a director effective June 19, 2026. He will serve until a successor is elected and qualified or he resigns, dies, or is removed under standard board governance terms.
What is Steven N. Gordon’s background at Celularity (CELU)?
Steven N. Gordon has served as EVP, Business Affairs since January 2026 and has been involved in Celularity’s financing, restructuring and strategic initiatives, bringing experience in corporate finance, operations, strategic development and capital formation in the biotechnology sector.
What experience does K. Harold Fletcher bring to Celularity (CELU)?
K. Harold Fletcher has extensive experience in corporate governance, securities law, strategic transactions, financings, healthcare compliance and public company matters, and previously served as Celularity’s General Counsel, Chief Compliance Officer and Assistant Corporate Secretary before his June 19, 2026 promotion.